Protembis
GermanyEntry
2024
Hold
2yr
Status
Active
Who owns Protembis?
Protembis is currently owned by XGen Venture SGR through XGEN Venture Life Sciences Fund (2022 vintage), since 2024. Across its history, Protembis has been through 5 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-07
Most recent investor
XGen Venture SGRXGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
5 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by IFB Innovationsstarter, S-UBG AG Aachen Krefeld Mönchengladbach, coparion, Segulah Medical Acceleration and XGen Venture SGR since 2015.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Active
Co-held by IFB Innovationsstarter, S-UBG AG Aachen Krefeld Mönchengladbach, coparion, Segulah Medical Acceleration and XGen Venture SGR since 2015.
Co-invest · 5 holders · 2015 · present
IFB InnovationsstarterActive
2015 · present(11yr) · Innovationsstarter Fonds Hamburg I · 2012 · VC
coparionActive
2018 · present(8yr) · coparion · 2016 · VC
XGen Venture SGRActive
2024 · present(2yr) · XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
More from XGEN Venture Life Sciences Fund
Other portfolio companies in the same fund.
Italy
UK
Sweden
SwitzerlandMore PE-backed in MedTech
Comparable medtech deals from other GPs.
US
Ireland
Denmark
FranceTrack Protembis
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Protembis?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Protembis.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue